Related references
Note: Only part of the references are listed.Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Marianne Renner et al.
NEURON (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
A beta aggregation and possible implications in Alzheimer's disease pathogenesis
Prashant R. Bharadwaj et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Juha Lauren et al.
NATURE (2009)
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2008)
Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition
Dorothee Abramowski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Diffusion in brain extracellular space
Eva Sykova et al.
PHYSIOLOGICAL REVIEWS (2008)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
Activity changes and marked stereotypic behavior precede Aβ pathology in TgCRND8 Alzheimer mice
Oliver Ambree et al.
NEUROBIOLOGY OF AGING (2006)
Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity:: a potent role for trimers
M Townsend et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice
LA Hyde et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Cortical synaptic integration in vivo is disrupted by amyloid-β plaques
EA Stern et al.
JOURNAL OF NEUROSCIENCE (2004)
In vivo reduction of amyloid-β by a mutant copper transporter
AL Phinney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Long-term potentiation is increased in the CA1 area of the hippocampus of APPswe/ind CRND8 mice
T Jolas et al.
NEUROBIOLOGY OF DISEASE (2002)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Plaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer's disease
RB DeMattos et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus
HW Wang et al.
BRAIN RESEARCH (2002)
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
MA Chishti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution
F Massi et al.
BIOPHYSICAL JOURNAL (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Enhanced synaptic potentiation in transgenic mice expressing presenilin 1 familial Alzheimer's disease mutation is normalized with a benzodiazepine
SH Zaman et al.
NEUROBIOLOGY OF DISEASE (2000)
Share Paper
